Synaptic loss caused by the release of Aβ(1–42) in AD occurs via α7 nicotinic acetylcholine receptors [also known as cholinergic receptor nicotinic alpha 7 subunit/CHRNA7; Talantova et al., 2013]. Here, CHRNA7 is linked to Alzheimer disease.